Post-transcriptional control of haemostatic genes: mechanisms and emerging therapeutic concepts in thrombo-inflammatory disorders
Abstract The haemostatic system is pivotal to maintaining vascular integrity. Multiple components involved in blood coagulation have central functions in inflammation and immunity. A derailed haemostasis is common in prevalent pathologies such as sepsis, cardiovascular disorders, and lately, COVID-1...
Gespeichert in:
| Veröffentlicht in: | Cardiovascular research Jg. 119; H. 8; S. 1624 - 1640 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
US
Oxford University Press
06.07.2023
|
| Schlagworte: | |
| ISSN: | 0008-6363, 1755-3245, 1755-3245 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Abstract
The haemostatic system is pivotal to maintaining vascular integrity. Multiple components involved in blood coagulation have central functions in inflammation and immunity. A derailed haemostasis is common in prevalent pathologies such as sepsis, cardiovascular disorders, and lately, COVID-19. Physiological mechanisms limit the deleterious consequences of a hyperactivated haemostatic system through adaptive changes in gene expression. While this is mainly regulated at the level of transcription, co- and posttranscriptional mechanisms are increasingly perceived as central hubs governing multiple facets of the haemostatic system. This layer of regulation modulates the biogenesis of haemostatic components, for example in situations of increased turnover and demand. However, they can also be ‘hijacked’ in disease processes, thereby perpetuating and even causally entertaining associated pathologies. This review summarizes examples and emerging concepts that illustrate the importance of posttranscriptional mechanisms in haemostatic control and crosstalk with the immune system. It also discusses how such regulatory principles can be used to usher in new therapeutic concepts to combat global medical threats such as sepsis or cardiovascular disorders. |
|---|---|
| AbstractList | Abstract
The haemostatic system is pivotal to maintaining vascular integrity. Multiple components involved in blood coagulation have central functions in inflammation and immunity. A derailed haemostasis is common in prevalent pathologies such as sepsis, cardiovascular disorders, and lately, COVID-19. Physiological mechanisms limit the deleterious consequences of a hyperactivated haemostatic system through adaptive changes in gene expression. While this is mainly regulated at the level of transcription, co- and posttranscriptional mechanisms are increasingly perceived as central hubs governing multiple facets of the haemostatic system. This layer of regulation modulates the biogenesis of haemostatic components, for example in situations of increased turnover and demand. However, they can also be ‘hijacked’ in disease processes, thereby perpetuating and even causally entertaining associated pathologies. This review summarizes examples and emerging concepts that illustrate the importance of posttranscriptional mechanisms in haemostatic control and crosstalk with the immune system. It also discusses how such regulatory principles can be used to usher in new therapeutic concepts to combat global medical threats such as sepsis or cardiovascular disorders. The haemostatic system is pivotal to maintaining vascular integrity. Multiple components involved in blood coagulation have central functions in inflammation and immunity. A derailed haemostasis is common in prevalent pathologies such as sepsis, cardiovascular disorders, and lately, COVID-19. Physiological mechanisms limit the deleterious consequences of a hyperactivated haemostatic system through adaptive changes in gene expression. While this is mainly regulated at the level of transcription, co- and posttranscriptional mechanisms are increasingly perceived as central hubs governing multiple facets of the haemostatic system. This layer of regulation modulates the biogenesis of haemostatic components, for example in situations of increased turnover and demand. However, they can also be 'hijacked' in disease processes, thereby perpetuating and even causally entertaining associated pathologies. This review summarizes examples and emerging concepts that illustrate the importance of posttranscriptional mechanisms in haemostatic control and crosstalk with the immune system. It also discusses how such regulatory principles can be used to usher in new therapeutic concepts to combat global medical threats such as sepsis or cardiovascular disorders. The haemostatic system is pivotal to maintaining vascular integrity. Multiple components involved in blood coagulation have central functions in inflammation and immunity. A derailed haemostasis is common in prevalent pathologies such as sepsis, cardiovascular disorders, and lately, COVID-19. Physiological mechanisms limit the deleterious consequences of a hyperactivated haemostatic system through adaptive changes in gene expression. While this is mainly regulated at the level of transcription, co- and posttranscriptional mechanisms are increasingly perceived as central hubs governing multiple facets of the haemostatic system. This layer of regulation modulates the biogenesis of haemostatic components, for example in situations of increased turnover and demand. However, they can also be 'hijacked' in disease processes, thereby perpetuating and even causally entertaining associated pathologies. This review summarizes examples and emerging concepts that illustrate the importance of posttranscriptional mechanisms in haemostatic control and crosstalk with the immune system. It also discusses how such regulatory principles can be used to usher in new therapeutic concepts to combat global medical threats such as sepsis or cardiovascular disorders.The haemostatic system is pivotal to maintaining vascular integrity. Multiple components involved in blood coagulation have central functions in inflammation and immunity. A derailed haemostasis is common in prevalent pathologies such as sepsis, cardiovascular disorders, and lately, COVID-19. Physiological mechanisms limit the deleterious consequences of a hyperactivated haemostatic system through adaptive changes in gene expression. While this is mainly regulated at the level of transcription, co- and posttranscriptional mechanisms are increasingly perceived as central hubs governing multiple facets of the haemostatic system. This layer of regulation modulates the biogenesis of haemostatic components, for example in situations of increased turnover and demand. However, they can also be 'hijacked' in disease processes, thereby perpetuating and even causally entertaining associated pathologies. This review summarizes examples and emerging concepts that illustrate the importance of posttranscriptional mechanisms in haemostatic control and crosstalk with the immune system. It also discusses how such regulatory principles can be used to usher in new therapeutic concepts to combat global medical threats such as sepsis or cardiovascular disorders. |
| Author | Castoldi, Elisabetta Danckwardt, Sven Trégouët, David-Alexandre |
| Author_xml | – sequence: 1 givenname: Sven orcidid: 0000-0002-3176-2265 surname: Danckwardt fullname: Danckwardt, Sven email: Sven.Danckwardt@unimedizin-mainz.de – sequence: 2 givenname: David-Alexandre orcidid: 0000-0001-9084-7800 surname: Trégouët fullname: Trégouët, David-Alexandre – sequence: 3 givenname: Elisabetta surname: Castoldi fullname: Castoldi, Elisabetta email: e.castoldi@maastrichtuniversity.nl |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36943786$$D View this record in MEDLINE/PubMed |
| BookMark | eNo9kc1LxDAQxYMo7rp68i45iZdq0jRp600Wv2BBD3ouaTrdjTRJTVJhj_7nZnH1MAwz78eDmXeCDq2zgNA5JdeU1OxGfflUsiOFOEBzWnKesbzgh2hOCKkywQSboZMQPtLIeVkcoxkTdcHKSszR96sLMYte2qC8HqN2Vg5YORu9G7Dr8UaCSYiMWuE1WAi32IDaSKuDCVjaDoMBv9Z2jeMGvBxh2qHJQcEYA9Y27b0zrcu07QdpjIzOb3Gng_Md-HCKjno5BDjb9wV6f7h_Wz5lq5fH5-XdKlMFZTFrSSEBaE_qWtSMiLxoOyBMtYRxJaAWfVtC2-V9ukzwirOW1hVQRiqehIqyBbr69R29-5wgxMbooGAYpAU3hSYvqzpnvCQkoRd7dGoNdM3otZF-2_y9LQGXv4Cbxn-VkmaXR5PyaPZ5sB9k4YGF |
| CitedBy_id | crossref_primary_10_1055_s_0044_1782519 crossref_primary_10_1186_s12879_025_10848_z crossref_primary_10_1007_s00018_024_05304_1 crossref_primary_10_3390_biom13091318 crossref_primary_10_1186_s12864_023_09460_9 crossref_primary_10_1016_j_jtha_2023_05_026 crossref_primary_10_5847_wjem_j_1920_8642_2025_033 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. 2023 The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. |
| Copyright_xml | – notice: The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. 2023 – notice: The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. |
| DBID | TOX NPM 7X8 |
| DOI | 10.1093/cvr/cvad046 |
| DatabaseName | Oxford Journals Open Access Collection PubMed MEDLINE - Academic |
| DatabaseTitle | PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1755-3245 |
| EndPage | 1640 |
| ExternalDocumentID | 36943786 10.1093/cvr/cvad046 |
| Genre | Journal Article |
| GroupedDBID | --- --K -E4 .2P .55 .GJ .I3 .ZR 08P 0R~ 18M 1B1 1TH 29B 2WC 3O- 4.4 48X 53G 5GY 5RE 5VS 5WD 6.Y 6J9 70D AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AASNB AAUAY AAUQX AAVAP AAWDT ABEUO ABHFT ABIXL ABJNI ABKDP ABLJU ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABQTQ ABSAR ABSMQ ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACMRT ACPQN ACUFI ACUTJ ACUTO ACYHN ACZBC ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEJOX AEKPW AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFIYH AFOFC AFSHK AFXAL AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AGUTN AHXPO AI. AIAGR AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT APJGH APWMN AQDSO AQKUS ASPBG ATGXG ATTQO AVNTJ AVWKF AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM BZKNY C45 CDBKE CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EIHJH EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IHE IOX J21 J5H JXSIZ KAQDR KBUDW KC5 KOP KSI KSN L7B LMP M-Z M41 M49 MBLQV MHKGH MJL N4W N9A NGC NOMLY NOYVH NQ- NU- NVLIB O0~ O9- OAUYM OAWHX OCZFY ODMLO OJQWA OJZSN OK1 OOVWX OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM Q1. Q5Y QBD R44 RD5 RIG ROL ROX ROZ RPZ RUSNO RW1 RXO SEL SV3 TCURE TEORI TJX TMA TOX VH1 W8F WH7 X7H X7M XPP YAYTL YKOAZ YXANX ZGI ZXP ~91 ABDFA ABEJV ABGNP ABPQP ABVGC ADNBA AEMQT AHMMS AJNCP ALXQX NPM 7X8 AHGBF AJBYB |
| ID | FETCH-LOGICAL-c413t-b04aee1f0996930624bde03cb035c6e96fb7ebd2f94365853b198e13085b7e813 |
| IEDL.DBID | TOX |
| ISICitedReferencesCount | 8 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001000384100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0008-6363 1755-3245 |
| IngestDate | Sun Sep 28 11:03:32 EDT 2025 Thu Apr 03 06:55:21 EDT 2025 Wed Aug 28 03:17:25 EDT 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 8 |
| Keywords | ceRNA Biomarker lncRNA circRNA Splicing protein modification RNA-binding proteins Signalling RNA (m Polyadenylation miRNA A) modification noncoding RNAs RNA (m6A) modification |
| Language | English |
| License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c413t-b04aee1f0996930624bde03cb035c6e96fb7ebd2f94365853b198e13085b7e813 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
| ORCID | 0000-0001-9084-7800 0000-0002-3176-2265 |
| OpenAccessLink | https://dx.doi.org/10.1093/cvr/cvad046 |
| PMID | 36943786 |
| PQID | 2789235700 |
| PQPubID | 23479 |
| PageCount | 17 |
| ParticipantIDs | proquest_miscellaneous_2789235700 pubmed_primary_36943786 oup_primary_10_1093_cvr_cvad046 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-07-06 |
| PublicationDateYYYYMMDD | 2023-07-06 |
| PublicationDate_xml | – month: 07 year: 2023 text: 2023-07-06 day: 06 |
| PublicationDecade | 2020 |
| PublicationPlace | US |
| PublicationPlace_xml | – name: US – name: England |
| PublicationTitle | Cardiovascular research |
| PublicationTitleAlternate | Cardiovasc Res |
| PublicationYear | 2023 |
| Publisher | Oxford University Press |
| Publisher_xml | – name: Oxford University Press |
| References | 37327071 - Cardiovasc Res. 2023 Jun 16 |
| References_xml | – reference: 37327071 - Cardiovasc Res. 2023 Jun 16;: |
| SSID | ssj0005574 |
| Score | 2.4647858 |
| SecondaryResourceType | review_article |
| Snippet | Abstract
The haemostatic system is pivotal to maintaining vascular integrity. Multiple components involved in blood coagulation have central functions in... The haemostatic system is pivotal to maintaining vascular integrity. Multiple components involved in blood coagulation have central functions in inflammation... |
| SourceID | proquest pubmed oup |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1624 |
| Title | Post-transcriptional control of haemostatic genes: mechanisms and emerging therapeutic concepts in thrombo-inflammatory disorders |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36943786 https://www.proquest.com/docview/2789235700 |
| Volume | 119 |
| WOSCitedRecordID | wos001000384100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBbtUkovbfpIsm2yVSFXUXn1sNxbCQk5JNs9bME3I8njZg-2w9rJvf-8I1ublm0gOdgYZAsxM8yMmfnmI-REK49ezmcscwqYtPjkLHeMlykmx9aVZhziepkuFibPs2VskO0eKOFn4qu_2-BlS_yTQ1ebKBPMefUj_9vJoeKwZW6YFlpEGN7OtzsItv8SySGgnL956lH2yOuYMtLvo47fkmfQvCMvr2JR_D35HQh3WR-CztYF4OuxB522Fb22ULcBObT29Ffwbd9oDQHxu-7qjtqmpAElHNiK6D9wrLBD6Hnp6LqhgU2hdi1De0QTqofSPC3j5M7uA_l5frY6vWCRWYF5DFo9c1xagKTC9DBQIeq5dCVw4R0XymvIdOVScOW8yqTAFEUJl2QGMNwZhQsmEftk0rQNHBLKk0qmLrPgoZIwV45bo6QsPehKa2mn5DOKvbgZZ2cUY81bFCjJIkpySr5sVVKgbYeChW2gve2KgNIN43g4n5KDUVf3GwmNZ0uN_vjo_p_Iq8ARP_TY6iMy6Te3cExe-Lt-3W1m5HmaG7wvllezwaz-ALlKzDI |
| linkProvider | Oxford University Press |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Post-transcriptional+control+of+haemostatic+genes%3A+mechanisms+and+emerging+therapeutic+concepts+in+thrombo-inflammatory+disorders&rft.jtitle=Cardiovascular+research&rft.au=Danckwardt%2C+Sven&rft.au=Tr%C3%A9gou%C3%ABt%2C+David-Alexandre&rft.au=Castoldi%2C+Elisabetta&rft.date=2023-07-06&rft.pub=Oxford+University+Press&rft.issn=0008-6363&rft.eissn=1755-3245&rft.volume=119&rft.issue=8&rft.spage=1624&rft.epage=1640&rft_id=info:doi/10.1093%2Fcvr%2Fcvad046&rft.externalDocID=10.1093%2Fcvr%2Fcvad046 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-6363&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-6363&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-6363&client=summon |